Innovative Snake Antivenom Solutions for Global Health Challenges

Advancing Global Access to Snake Antivenoms: The Role of IgY(ΔFc) Technology

Global Burden of Snakebites and the Shortage of Antivenoms

The global unavailability of effective snake antivenoms to treat specific types of envenoming has become a critical health issue. The World Health Organization (WHO) emphasizes the urgent need to ensure the availability of safe, effective, and affordable antivenoms, especially in developing countries.


IgY(ΔFc)-Based Snake Antivenom Immunoglobulins

Good Biotech has developed a proprietary platform for snake antivenoms, including a rapid snake venom test kit. This platform enables the development and optimization of species-specific IgY(ΔFc) antibody-derived snake antivenoms for effective regional management. We offer:

  • Monospecific Snake Antivenoms:
    • Neurotoxic
    • Hematotoxic
  • Polyspecific Snake Antivenoms:
  • Neurotoxic
  • Hematotoxic

Studies from the Taiwan Centers for Disease Control demonstrate that IgY(ΔFc)-derived antivenoms significantly outperform traditional equine-based antivenoms in safety, efficacy, productivity, and cost-effectiveness. Our technology also enables rapid mass production and aligns with animal protection trends.


Advantages Over Classical Equine IgG-Based Antivenoms

  • Higher Neutralization Activity: 10-20 times more effective per unit of antibody.
  • Enhanced Productivity: Over 100 times more productive.
  • Faster Immunological Response: Effective titers achieved within two weeks of immunization.
  • 100% Immune Response Rate: Consistent results.
  • Safer and More Efficient: IgY(ΔFc) antibodies derived from egg yolk, unlike horse IgG, avoid the risk of life-threatening allergic reactions. IgY(ΔFc) antivenoms also contain lower levels of heterologous proteins, reducing the risk of serum sickness.
  • Cost-Effective: More than 90% reduction in production costs.
  • Simple Production Process: No need for blood/plasma collection or complex fragment processing. High-purity IgY(ΔFc) antibodies are obtained from egg yolk using our proprietary technology.
  • Meets Animal Protection Standards: IgY(ΔFc) technology addresses the growing concerns of animal welfare and is compliant with regulations promoting animal protection.

Innovative Solutions to Address Unmet Medical Needs

Good Biotech’s IgY(ΔFc)-derived snake antivenoms offer a fast, safe, effective, and affordable solution to the global need for antivenom immunoglobulins. Key benefits include:

  • High-Quality, Low-Cost Polyspecific and Monospecific Antivenoms: Tailored for regional species.
  • Rapid Snake Venom Test Kit: A world-first one-step test that provides fast (3-5 minutes) venom detection, enabling more precise and effective medical intervention.
  • Large-Scale Production: Consistent batch-to-batch quality and availability.
  • Lyophilized Powder Form: Easy to store and transport, especially in areas without refrigeration.
  • Scalable Production: The technology enables the large-scale, fast, and cost-effective production of highly specific snake antivenoms, tailored to different regions worldwide.

Partnering with Good Biotech: Addressing the Global Snakebite Crisis with Advanced Antivenom Solutions

Good Biotech is seeking collaboration with global pharmaceutical companies to advance the development and distribution of our mature, large-scale production of snake antivenom immunoglobulins.

If you are interested in partnering with us, please contact our Partnering Team at partnership@good-biotech.com.

Related Information: IgY(ΔFc) Antibody-Based Snake Venom Rapid Test Kit